Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
Condition(s):AsthmaLast Updated:August 23, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:August 23, 2011Unknown status
Condition(s):Moderate AsthmaLast Updated:December 8, 2023Completed
Condition(s):Moderate AsthmaLast Updated:May 2, 2017Terminated
Condition(s):Asthma in Children; Asthma AttackLast Updated:March 6, 2024Recruiting
Condition(s):AsthmaLast Updated:March 15, 2012Completed
Condition(s):AsthmaLast Updated:June 16, 2010Completed
Condition(s):Asthma; Mild Asthma; Moderate AsthmaLast Updated:November 28, 2023Recruiting
Condition(s):Mild to Moderate AsthmaLast Updated:August 27, 2010Completed
Condition(s):Asthma; Efficacy; SafetyLast Updated:February 15, 2018Completed
Condition(s):Asthma; Moderate AsthmaLast Updated:December 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.